Skip to content
cropped-cropped-asthma-foundation.jpg
World Asthma Foundation

World Asthma Foundation

Breathe Well Live Well

  • Home
  • About
    • Mission and Vision
    • Site Map
    • Defeating Asthma Series
      • Defeating Asthma Project
        • Defeating Asthma Project
        • Defeating Asthma Series
        • Asthma and the Microbiome
    • Key Initiatives
      • Advisory Board
      • World Asthma Day
      • Press Releases
      • In Memoriam
  • Blog
    • Blog
    • Defeating Asthma Series
    • Asthma and the Microbiome
    • Featured Stories and Interviews
    • Asthma News
    • Breathe Well Live Well Blog
    • Asthma Research and Studies
    • Asthma Prevention
    • Asthma Clinical Trials U.S.
    • Asthma Studies
    • Asthma and Allergies
  • Sign Up for Newsletter
  • Patients
    • For Asthma Patients
    • Site Map
    • Defeating Asthma Series
    • Use and Privacy Policy
    • What Causes Asthma?
    • War On Asthma
    • Asthma History and Timeline
    • Asthma Survival Guide
    • Asthma Facts
    • Asthma Clinical Trials U.S.
    • Asthma-COPD Buyer’s Guide
    • Asthma & Aspirin Sensitivity
    • Indoor Environmental Asthma Triggers
    • Pulmonary Funct Test
    • Asthma Action Plan
    • Asthma & Allergies
    • Inhalers & Spacers
    • Asthma & Nasal Rinse
  • Support WAF
    • Defeat Asthma: 10 Simple Steps
    • Speak out for Asthma
  • Severe Asthma Survey
  • Contact

Tag: MSTT1041A

Posted on September 30, 2016

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma

Condition:   Asthma
Interventions:   Drug: MSTT1041A;   Drug: Placebo
Sponsor:   Hoffmann-La Roche
Recruiting – verified September 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

  • Indoor Chemical Exposure: What the Public, Clinicians and Contractors Need to Know
  • World Asthma Day 2025: Reframing Severe Asthma – From Root Causes to Real-World Solutions
  • Breaking New Ground in Airway Mycosis: Insights from Dr. David Corry
  • Welcome to the World Asthma Foundation Symposium
  • Meet the Fungi: “Unveiling the Mysteries of Airway Mycosis” Symposium
  • How Common Bacteria Evade the Immune System and Cause Persistent Illness
  • Asthma News: Your Weekly Dose of Asthma Information

Subscribe

* indicates required

  • Asthma and AERD
  • Asthma and Allergies
  • Asthma and Bacteria
  • Asthma and Chemical Sensitivity
  • Asthma and Children
  • Asthma and COVID19
  • Asthma and Fungi
  • Asthma and Genetics
  • Asthma and Molds
  • Asthma and the Microbiome
  • Asthma Awareness Month
  • Asthma Champions
  • Asthma Clinical Trials U.S.
  • Asthma Conference and Events
  • Asthma News
  • Asthma Prevention
  • Asthma Research and Studies
  • Asthma Studies
  • Asthma Treatment Centers
  • Asthma-COPD Overlap Syndrome
  • Breathe Well Live Well Blog
  • CDC Watch
  • COPD
  • Defeating Asthma Series
  • Featured Stories and Interviews
  • In Memoriam
  • Infections and Asthma
  • Mycoplasma pneumoniae
  • Non-Eosinophilic Asthma
  • Phage
  • Press Releases
  • Severe Asthma
  • Severe Asthma Series
  • Third Party Articles
  • U.S. National Library of Medicine (NIH)
  • Uncategorized
  • US EPA Watch
  • World Asthma Day

On Facebook and Twitter

Facebook Asthma Foundation

Twitter Asthma Facts

Defeating Asthma Project

  • Use and Privacy Policy
  • DMCA
  • Terms of Use
Proudly powered by WordPress